Technical analysis of Inotiv, Inc. (NOTV): price and volume charts, candlestick patterns, moving averages (SMA, EMA), RSI, MACD, ADX and Bollinger Bands. Identify momentum, trend direction and potential entry/exit zones.
Inotiv, Inc. provides nonclinical and analytical drug discovery and development services to the pharmaceutical and medical device industries in the United States, the Netherlands, and internationally. The company operates through two segments, Discovery and Safety Assessment (DSA) and Research Models and Services (RMS).
Price Performance
| 1 month | +0.00% |
| 3 months | +0.00% |
| Year-to-date | -85.79% |
| 1 year | -93.99% |
| 3 years | -97.54% |
| 5 years | -99.77% |
52-Week Range
| 52-week High | $2.95 |
| 52-week Low | $0.08 |
| Avg Volume (90d) | 14.0M |
Technical Indicators
| SMA 50 | $0.26 |
| SMA 200 | $0.71 |
| Beta | 4.08 |
| 30-day Volatility (annualised) | 346.2% |
| Price vs SMA 50 | -69.0% |
| Price vs SMA 200 | -88.8% |
Monthly Close (12 months)
| Month | Close | Change |
|---|
| 2025-10 | $1.33 | |
| 2025-11 | $0.93 | -30.4% |
| 2025-12 | $0.56 | -39.3% |
| 2026-01 | $0.50 | -11.0% |
| 2026-02 | $0.27 | -45.9% |
| 2026-03 | $0.27 | +0.7% |
| 2026-04 | $0.29 | +6.5% |
| 2026-05 | $0.29 | -1.4% |
| 2026-06 | $0.08 | -72.1% |
Upcoming Earnings
| Date | EPS Est. | Revenue Est. |
|---|
| 2026-09-14 | $-2.53 | |
| 2026-09-14 | | $159M |
| 2026-09-14 | $-0.26 | $14M |
| 2026-09-14 | | |
| 2026-09-14 | $0.84 | $26M |
| 2026-09-14 | | |
Price
| Price | $0.08 |
| Market Cap | $3M |
| Exchange | NASDAQ |
| Country | US |
Valuation Ratios
| Price / Book | 0.04 |
| EV / EBITDA | 46.61 |
| Dividend Yield | 0.00% |
Financial Health
| Debt / Equity | 6.33 |
| Current Ratio | 0.27 |